These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6249520)

  • 1. An improved method for the detection of heterozygosity of congenital virilizing adrenal hyperplasia.
    Lejeune-Lenain C; Cantraine F; Dufrasnes M; Prevot F; Wolter R; Franckson JR
    Clin Endocrinol (Oxf); 1980 Jun; 12(6):525-35. PubMed ID: 6249520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygotes for 17 alpha-hydroxylase deficiency can be detected with a short ACTH test.
    Wit JM; van Roermund HP; Oostdijk W; Benraad TJ; Thijssen JH; Boer P; Jansen M; Spit M; van den Brande JL
    Clin Endocrinol (Oxf); 1988 Jun; 28(6):657-64. PubMed ID: 2855412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone preparation does not alter corticoid and androgen responses to adrenocorticotropin.
    Rosenfield RL; Helke J; Lucky AW
    J Clin Endocrinol Metab; 1985 Mar; 60(3):585-9. PubMed ID: 2982902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening heterozygotes for 21-hydroxylase deficiency among hirsute women: lack of utility of the adrenocorticotropin hormone test.
    Dewailly D; Vantyghem MC; Lemaire C; Dufosse F; Racadot A; Fossati P
    Fertil Steril; 1988 Aug; 50(2):228-32. PubMed ID: 2840308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
    Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
    Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
    Dörr HG; Sippell WG
    J Clin Endocrinol Metab; 1993 Jan; 76(1):117-20. PubMed ID: 8421074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test.
    Pang S; Carbunaru G; Haider A; Copeland KC; Chang YT; Lutfallah C; Mason JI
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):323-31. PubMed ID: 12608938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocorticotrophin stimulation and HLA polymorphisms suggest a high frequency of heterozygosity for steroid 21-hydroxylase deficiency in patients with Turner's syndrome and their families.
    Larizza D; Cuccia M; Martinetti M; Maghnie M; Dondi E; Salvaneschi L; Severi F
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):39-45. PubMed ID: 8306479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kyritsi EM; Koltsida G; Farakla I; Papanikolaou A; Critselis E; Mantzou E; Zoumakis E; Kolaitis G; Chrousos GP; Charmandari E
    Hormones (Athens); 2017 Jan; 16(1):42-53. PubMed ID: 28500827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygote detection in congenital adrenal hyperplasia.
    Handelsman DJ; Howe CJ; Conway AJ; Turtle JR
    Clin Chem; 1983 Jan; 29(1):48-50. PubMed ID: 6848281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening 21-hydroxylase deficiency carriers in androgen excess women of Chinese Han nationality].
    Tao H; Lu Z; Zhang B; Wang Y; Sun M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):195-7. PubMed ID: 15793784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of heterozygotes for congenital adrenal hyperplasia: 21-hydroxylase deficiency-a comparison of HLA typing and 17-OH progesterone response to ACTH infusion.
    Mauseth RS; Hansen JA; Smith EK; Giblett ER; Kelley VC
    J Pediatr; 1980 Nov; 97(5):749-53. PubMed ID: 6253614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of the heterozygote carrier state in 21-hydroxylase deficiency using steroids].
    Sulcová J; Hampl R; Foretová L; Vána V; Stárka L
    Vnitr Lek; 1990 Jul; 36(7):643-8. PubMed ID: 2174197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detection of the heterozygous carrier for congenital virilizing adrenal hyperplasia.
    Gutai JP; Kowarski AA; Migeon CJ
    J Pediatr; 1977 Jun; 90(6):924-9. PubMed ID: 192874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital adrenal hyperplasia in adolescents: diagnosis and management.
    Lin-Su K; Nimkarn S; New MI
    Ann N Y Acad Sci; 2008; 1135():95-8. PubMed ID: 18574213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
    Lucky AW; Rosenfield RL; McGuire J; Rudy S; Helke J
    J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
    Lee CT; Tung YC; Hsiao PH; Lee JS; Tsai WY
    J Formos Med Assoc; 2010 Feb; 109(2):148-55. PubMed ID: 20206839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
    Morris AH; Reiter EO; Geffner ME; Lippe BM; Itami RM; Mayes DM
    J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
    J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.